QUANTUM X LABS INC. quarterly report, Q1 FY2021

Business Context and Reporting Period

The supplied filing is Viewbix Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2021; it does not identify Quantum X Labs Inc. as the registrant. Viewbix describes itself as an interactive video technology and data platform. Unless noted otherwise, financial amounts below are in thousands of U.S. dollars.

Financial Results and Liquidity

MetricQ1 2021Q1 2020 / comparison
Revenue$8$37
Gross profit$8$33
Gross margin100%Approximately 89%
Operating loss$73$200
Net loss$80$174
Net loss per share$0.002$0.006
Cash used in operating activities$14Cash provided of $10

Revenue and operating expenses declined year over year; management attributed lower revenue and research, selling and administrative expenses to cost reductions begun in January 2020. Net financial results shifted from $28 of income to $7 of expense, which management attributed mainly to foreign exchange movements and the loan’s interest cost.

At March 31, 2021, cash was $134, total current assets $196, and current liabilities $2,354, including $2,104 payable to parent Gix and a $54 net short-term loan. Working capital was negative $2,158, and stockholders’ deficit was $2,158. Cash declined from $148 at December 31, 2020. The filing reports no investing cash flow in Q1 2021. No committed external funding source is identified.

Outlook, Risks, and Other Matters

  • Going concern: Management expects substantial operating losses and says the company needs additional capital. The filing states that these conditions raise substantial doubt about its ability to continue as a going concern; prospective funding is uncertain.
  • Financing and dilution: Management expects to seek equity or debt financing and strategic arrangements. Financing may be unavailable or costly, dilute shareholders, or require concessions; failure to raise funds could force reductions or termination of operations.
  • Controls: Management concluded disclosure controls were not effective at a reasonable assurance level because of a material weakness in period-end financial reporting.
  • Litigation: A former CEO seeks approximately $225 in damages in a wrongful-termination case. Management, with legal counsel, believes the claims will not succeed; the company’s court summaries were due by May 20, 2021.
  • Other risks: The company says COVID-19’s full business impact cannot be estimated. It also cites limited capital, customer retention, management turnover, competition, intellectual property protection, and technology obsolescence risks. No specific revenue or earnings guidance is provided.

Important Facts to Verify

  • Confirm the intended issuer: the source filing is for Viewbix Inc. (ticker VBIX), not Quantum X Labs Inc.
  • Assess near-term liquidity and the status, terms, and availability of additional financing, particularly given the large parent-company payable and going-concern warning.
  • Review remediation of the disclosed financial-reporting material weakness.
  • Track the former CEO litigation and any subsequent developments.
  • Review potential dilution from 7,298,636 outstanding warrants and the additional 1,642,193 shares potentially issuable to Gix upon specified product launches.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.